What stage of smoking cessation is a patient in who has recently quit smoking, is motivated to quit, and is using nicotine replacement therapy (NRT) patches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Action Stage

This patient is in the Action stage of smoking cessation. The patient has recently stopped smoking and is actively using nicotine replacement therapy (NRT) patches, which represents concrete behavioral change and active implementation of cessation strategies 1, 2.

Understanding the Stages of Change Model

The stages of smoking cessation follow a well-defined progression 1, 3:

  • Precontemplation: No thoughts of quitting smoking 1, 3
  • Contemplation: Thinking about quitting but not ready to take action 1, 3
  • Preparation: Planning to quit within the next 30 days 1, 3
  • Action: Actively quitting and maintaining abstinence for up to 6 months 1, 2, 3
  • Maintenance: Sustained abstinence beyond 6 months 1, 3

Why This Patient is in the Action Stage

The patient has already quit smoking and is using pharmacotherapy, which definitively places them in the Action stage 1, 2. The Action stage is characterized by:

  • Active cessation behavior: The patient has stopped smoking cigarettes 1, 2
  • Use of cessation aids: The patient is using NRT patches as pharmacological support 2, 4
  • Motivation and commitment: The patient demonstrates active engagement in the quit process 1
  • Time frame: This stage encompasses the period from initial cessation up to 6 months of abstinence 1, 3

Clinical Management in the Action Stage

For patients in the Action stage, the focus shifts from motivation to relapse prevention and withdrawal management 5. Key interventions include:

Pharmacotherapy Optimization

  • Continue combination NRT: The patient should ideally use a 21 mg patch plus short-acting NRT (gum, lozenge, inhaler, or nasal spray) for breakthrough cravings, as combination therapy nearly doubles quit rates compared to patch alone 5, 6, 4
  • Minimum 12-week duration: Maintain pharmacotherapy for at least 12 weeks, with potential extension to 6-12 months to prevent relapse 5, 7
  • Early follow-up: Assess smoking status and medication side effects within 2-3 weeks of starting therapy 5, 7

Behavioral Support

  • Intensive counseling: Provide at least 4 sessions of 10-30+ minutes during the 12-week treatment period 5, 7
  • Skills training: Focus on identifying high-risk situations, developing coping strategies, and providing social support 5
  • Relapse prevention: Address withdrawal symptoms, which typically peak within 1-2 weeks and then subside 5

Risk Assessment for Relapse

Patients in the Action stage require ongoing assessment for relapse risk factors 5:

  • Frequent or intense cravings 5
  • Elevated anxiety, stress, or depression 5
  • Living or working with smokers 5
  • Time since quitting less than 1 year 5
  • Drug or alcohol use 5

Common Pitfall to Avoid

Do not assume the patient is in the Preparation stage simply because they are motivated. The Preparation stage specifically refers to smokers who are planning to quit within the next 30 days but have not yet quit 1, 3. This patient has already taken action by stopping smoking and initiating NRT, which moves them beyond preparation into active cessation 1, 2.

References

Research

Stage-based interventions for smoking cessation.

The Cochrane database of systematic reviews, 2010

Research

Nicotine replacement therapy for smoking cessation.

The Cochrane database of systematic reviews, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nicotine Replacement Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Varenicline Prescription and Administration Guidelines for Smoking Cessation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What stage of smoking cessation is a male patient in, who has come to a smoking cessation clinic willing to quit after purchasing a nicotine patch?
What stage of smoking cessation is a male patient in who is willing to quit and has purchased a nicotine patch?
What is the precontemplation stage of smoking (tobacco) cessation?
What are the recommendations for a patient with multiple sclerosis (MS) who smokes?
What is the appropriate management plan for a 40-year-old woman with hypertension, who is a smoker, overweight, and has been taking oral birth control for 20 years?
Can an endometrial ablation damage the bowel in patients with previous pelvic surgeries, endometriosis, or other conditions?
Can Vraylar (cariprazine) be added to the regimen of an adult patient with anxiety and possible psychotic disorders, currently taking Buspar (buspirone) 15mg twice daily (BID), Lorazepam (Ativan) 1mg three times daily (TID), and Seroquel (quetiapine) 400mg daily?
What is the best treatment approach for a patient with diabetes mellitus presenting with cellulitis?
What is the recommended treatment duration for cefdinir (Cephalosporin) in an adult patient with community-acquired pneumonia and no underlying medical conditions?
What is the recommended dose of Suboxone (buprenorphine/naloxone) for an adult patient with opioid use disorder and a history of moderate to severe pain?
Should I start heparin (anticoagulant) therapy in an adult patient with acute to early subacute myocardial infarction (heart attack) and a history of cardiovascular disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.